The Peter MacCallum Cancer Centre (Peter Mac) Graduate Nurse Program provides opportunities for graduate nurses to consolidate and expand their clinical ability, judgement and confidence while working as valued members of the organisation.
The program is structured to encourage reflective practice and to help new nurses begin to identify the many possibilities available in their nursing career.
There will be more than 30 graduate nurse positions available in 2021, with intakes in January and March.
The program may include two six-month rotations or an allocation to one ward or unit for the duration of the program. Please see areas where graduate nurses are allocated below:
32 bed ward with a clinical (medical) focus on people who have been diagnosed with cancers involving:
- bone and soft tissue
- skin, and melanoma
- head and neck
- genito –urinary and
- gynaecological systems
The ward may also manage paediatric patients. Treatment modalities provided to patients on Ward 3A include: chemotherapy, external beam radiotherapy, nuclear medicine treatments and palliative care. The ward incorporates a 4 bed 'first in human' Clinical Trials Unit.
The ward staff work in collaboration with [email protected] Peter Mac Victorian Adolescent & Young Adult Cancer Service. This service consists of a multidisciplinary team of healthcare professionals who work alongside cancer specialists at Peter Mac to ensure all aspects of a young person's health and wellbeing are given attention both during treatment and in the years beyond.
32 bed ward with a focus on people diagnosed with haematological and breast cancers. Haematological malignancies include:
- lymphoma and
- myeloproliferative neoplasms
Treatment modalities provided to patients on Ward 5A include: chemotherapy, radiotherapy, antibody therapies, autologous stem cell transplantation.
32 bed ward with a clinical focus on people requiring surgery as part of their cancer treatment. This includes people who have been diagnosed with the following cancers:
- head and neck
- melanoma and
Ward 6A staff care for patients both pre-operatively and post-operatively and manages patients with surgical complications.
The Cancer Imaging Department provides a comprehensive range of general and specialist diagnostic, interventional and therapeutic services including:
- general x-ray
- diagnostic mammography
- multi-slice helical computerised tomography (CT)
- magnetic resonance imaging (MRI)
- positron emission tomography (PET)
- PET/CT co-registration
- diagnostic and therapeutic nuclear medicine
- selected interventional radiology procedures
- bone marrow biopsies
Patient management activities include: Central venous access device (CVAD) insertion and removal, barium and contrast studies, percutaneous nephrostomy and biliary drainage, percutaneous gastrostomy (PEG) tube insertion, inferior vena cava (IVC) filter insertion, general fluoroscopic procedures, insertion of hook needle wires for cancer localisations.
A comprehensive service for patients undergoing complex cancer surgery including;
- six theatres,
- two procedure rooms including dedicated endoscopy unit,
- day of surgery admission,
- anaesthetics, intra-operative and post-anaesthetic care,
- extended Recovery Unit for high acuity patients
Major surgical focus includes: colorectal, upper gastrointestinal, hepatobiliary, breast, urology, melanoma, skin, plastic reconstructive, head and neck surgery, sarcoma/vascular, robotic surgery for a number of specialities, high dose radiation (brachytherapy) for gynaecological and prostate cancers, intraoperative radiotherapy and chemotherapy.
Allocation to the operating suite within the Graduate Nurse Program is 12 months only. Allocation includes: Scrub/scout (12 months) or Anaesthetics (6 months)/Post Anaesthetic Care Unit (PACU) (6 months).
Day Therapy is an integration of the Same Day Services from Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the Royal Women’s Hospital. The service comprises of five areas:
- clinical trials
The Chemotherapy Service is a 48 chair service (with room to expand) to provide care for all tumour streams including:
- bone and soft tissues
- brain and spine
- skin and Melanoma
- upper gastrointestinal
Treatments include chemotherapy, immunotherapy and supportive medications.
Medical Day Unit (MDU)
This unit provides symptom control and management for patients receiving treatment and cares for unplanned and unwell oncology patients that have presented to the hospital via outpatient clinics or the Royal Melbourne and Royal Women's Hospitals. There will be some planned activity within this unit including the administration of non- cytotoxic infusions, and the care of patients post a bone marrow transplant.
Apheresis specialises in the use of cell separator machines designed to centrifuge blood into different components based on the specific gravity of cellular content. Although apheresis is predominantly haematology focused (both malignant and non-malignant), there are a large number of solid tumour streams, neurology and renal patients who are treated here, in addition to a significant blood-product-donor population. The most common procedures performed by the apheresis area of Peter Mac include:
- stem cell (HPC-A) Harvesting (both for autologous and allogeneic purposes)
- red cell exchange (RBCx) or Reduction
- plasma exchange (TPE)
- extracorporeal photopheresis (ECP)
- white blood cell reduction
- granulocyte harvesting.
The Transfusion unit specialises in the co-ordination and provision of all outpatient blood products to Peter Mac patients. The transfusion unit also provides regular administration of blood products for chronic disorders such as myelodysplastic syndrome (MDS) and disease related or treatment-induced hypogammaglobulinaemia. Common blood products administered within the transfusion lounge includes:
- packed red blood cell (PRBCS),
- plasma products including albumin, cryoprecipitate or fresh frozen plasma
- intravenous immunoglobulin (IVIG)
Clinical Trials Unit (CTU)
This unit will provide coordinated care to patients undergoing a Phase 1 or high risk clinical trials.
Allocation to Day Therapy, within the Graduate Nurse Program is 12 months only. Medical/Transfusion (6 months) and Chemotherapy (6 months)
To participate in Peter Mac’s Graduate Nurse Program, list the Peter MacCallum Cancer Centre as your hospital preference for a Victorian Graduate Nurse Program via the Postgraduate Medical Council of Victoria’s Allocation and Placment Service.
Graduate Nurse Program positions will be offered at 0.8 EFT, (Operating Suite 1.0 EFT) and applicants will need to provide the following:
- Letter of application with a passport sized photo
- Curriculum Vitae including a list of clinical placements
- Academic transcript with key (certified)
- Certified copies of two recent clinical appraisal tools (minimum of one acute placement)
- You will need to provide your referee details to the Placement and Allocation Service allocations.pmcv.com.au
Applications must be submitted using Peter Mac’s e-recruit system, and addressed to Ms. Michelle Rutherford, Graduate Nurse Program Coordinator.
Applicants successful for interview will be required to undertake an on-line interview in August/September 2020.
If your application is successful, you will be required to partake in an interview. An online video platform may be used.
Successful applicants will be notified via the Postgraduate Medical Council of Victoria’s (PMCV) Allocation and Management service website.